Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gelatin from BSE countries used in oral products exempt from FDA restrictions.

This article was originally published in The Tan Sheet

Executive Summary

GELATIN FROM BSE COUNTRIES USED IN ORAL PRODUCTS EXEMPT FROM FDA RESTRICTIONS on the use of bovine-derived materials, under an agency guidance announced in the Oct. 7 Federal Register. "There does not appear to be a basis for objection to the use of gelatin in FDA-regulated products for oral consumption and cosmetic use by humans when the gelatin is produced from bones obtained from cattle residing in, or originating from," countries where there are bovine spongiform encephalopathies "if the cattle come from BSE-free herds and if the slaughterhouse removes the heads, spines and spinal cords directly after slaughter," the guidance states.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087629

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel